Payload– tag –
-
UC Berkeley’s Doudna Lab Redesigns Minimal CRISPR Nucleases with AI, Revolutionizing In Vivo Delivery
CRISPR Medicine News USA Overview Researchers at UC Berkeley's Innovative Genomics Institute (IGI), including Jennifer Doudna, have published a Science paper detailing an AI-powered technique to minimize and redesign CRISPR nucleases. Th... -
ispace Secures 500kg Lunar Payload Capacity on SpaceX Starship for $50M, Launching Moon Ride-Share Service by 2030
Sahm Stock Trading USA Overview Japanese lunar transport company ispace announced a new low-cost lunar cargo service leveraging SpaceX's Starship. ispace has purchased 500kg of payload capacity for $50 million on a Starship mission proje... -
ESA Unveils Advanced Lunar Lander Strategy for Precision Exploration and Resource Utilization
ESA News Europe Overview The European Space Agency (ESA) has announced a comprehensive development program for advanced lunar lander technology. This initiative prioritizes pinpoint landing accuracy, robust power systems for extended ope... -
Microchip Technology Unveils Radiation-Hardened Microcontroller for Critical Space Applications, Ensuring High-Reliability Missions
Microchip Technology Product Announcement USA Overview Microchip Technology has announced a new radiation-hardened microcontroller designed to withstand the harsh radiation of the space environment. This device is specialized for high-re... -
ESA Fast-Tracks Next-Gen Satellite Constellation for Unprecedented Climate and Disaster Intelligence
European Space Agency (ESA) Official Announcement Europe Overview The European Space Agency (ESA) has announced the selection of a groundbreaking Earth observation satellite constellation project, poised to revolutionize climate change m... -
Perovskite-Silicon Tandem Cells Achieve Over 20% Higher Efficiency for Space Applications, Surpassing Conventional Solar Arrays
Nature Energy (Preprint) International Overview Perovskite-silicon tandem cells, developed to boost efficiency for space solar arrays, have demonstrated over 20% higher power conversion efficiency (cell efficiency exceeding 30%) compared... -
Antibody-Drug Conjugates (ADCs) Evolve to Standard of Care in Solid Tumor Treatment: 12 Approved, 300 in Development, Focusing on Patient Wellness and Dual-Payload Strategies
Cancer News - Binaytara USA Overview Antibody-drug conjugates (ADCs) have dramatically evolved from 'magic bullets' to a standard of care in cancer treatment, with 12 ADCs approved globally and over 300 in clinical development. This evol... -
SGN-CEACAM5C (PF-08046050) Antibody-Drug Conjugate Evaluated in Phase 1 Clinical Trial for Advanced Solid Tumors Including Colorectal Cancer
Fight Colorectal Cancer USA Overview The July 2026 clinical trials roundup highlighted the evaluation of SGN-CEACAM5C (PF-08046050), an antibody-drug conjugate (ADC), in a Phase 1 study for adult patients with advanced solid tumors, incl... -
Nava Therapeutics Raises $89 Million for Lipid Nanoparticle (LNP) Platform: Innovating RNA Therapeutic Delivery
Endpoints News USA Overview Nava Therapeutics announced the completion of an $89 million Series A funding round to advance its lipid nanoparticle (LNP) platform, specialized in efficient RNA-based therapeutic delivery. This substantial f... -
Lonza Offers Integrated ADC Clinical and Commercial Manufacturing Services, Covering Antibody to Sterile Fill-Finish
Lonza Switzerland Overview Lonza offers integrated development and manufacturing services for Antibody-Drug Conjugates (ADCs), encompassing antibodies, payloads, bioconjugation, and sterile fill and finish. The company operates GMP produ...
